LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial

C. Ciccarese, Serena Porcari, Sebastiano Buti, Giuseppe Fornarini, F. Primi, Giulia Claire Giudice, Alessandra Damassi, Julio Rodrigo Giròn Berrìos, Luciano Stumbo, Domenico Arduini, A. Severino, Debora Rondinella, Luca Masucci, Maurizio Sanguinetti, Antonio Gasbarrini, Giovanni Cammarota, Nicola Segata, G. Tortora, Gianluca Ianiro, Roberto Iacovelli